Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Galectin-3/galectin-8-IN-2 (Compound 57) is a dual inhibitor targeting the C-terminal domains of Galectin-3 and galectin-8, exhibiting dissociation constants (Kd) of 12.8 μM and 2.06 μM, respectively. It effectively inhibits the migration of MRC-5 lung fibroblast cells and serves as a potential research tool for studying cancer and tissue fibrosis [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Galectin-3/galectin-8-IN-2 (Compound 57) is a dual inhibitor targeting the C-terminal domains of Galectin-3 and galectin-8, exhibiting dissociation constants (Kd) of 12.8 μM and 2.06 μM, respectively. It effectively inhibits the migration of MRC-5 lung fibroblast cells and serves as a potential research tool for studying cancer and tissue fibrosis [1]. |
Molecular Weight | 557.47 |
Formula | C26H18Cl2N2O4S2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Galectin-3/galectin-8-IN-2 Immunology/Inflammation Galectin inhibitor inhibit